|
|
leukocyte cell cell adhesion
|
GO:0007159 |
14 |
0.719
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.576
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.534
|
|
|
|
immune response activating cell surface receptor signaling pathway
|
GO:0002429 |
72 |
0.440
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.409
|
|
|
|
regulation of actin filament polymerization
|
GO:0030833 |
38 |
0.371
|
|
|
|
regulation of actin nucleation
|
GO:0051125 |
4 |
0.356
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
85 |
0.317
|
Human |
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.315
|
|
|
|
regulation of arp2 3 complex mediated actin nucleation
|
GO:0034315 |
1 |
0.297
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.286
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.244
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.211
|
Human |
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.205
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.190
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.189
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.184
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.182
|
Human |
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.166
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.155
|
Human |
|
|
cellular extravasation
|
GO:0045123 |
17 |
0.151
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.147
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.147
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.145
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.140
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.133
|
Human |
|
|
leukocyte chemotaxis
|
GO:0030595 |
69 |
0.133
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.132
|
Human |
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.131
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.126
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.125
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.123
|
|
|
|
substrate adhesion dependent cell spreading
|
GO:0034446 |
30 |
0.121
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.119
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.114
|
|
|
|
actin polymerization or depolymerization
|
GO:0008154 |
54 |
0.113
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.112
|
Human |
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.105
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.104
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.103
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.101
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.101
|
Human |
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.101
|
|
|
|
mesodermal cell migration
|
GO:0008078 |
4 |
0.099
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.099
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.098
|
Human |
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.097
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.095
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.091
|
Human |
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.091
|
|
|
|
granulocyte chemotaxis
|
GO:0071621 |
39 |
0.091
|
|
|
|
regulation of actin filament length
|
GO:0030832 |
45 |
0.090
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.090
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.089
|
|
|
|
immune response regulating cell surface receptor signaling pathway
|
GO:0002768 |
80 |
0.089
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.088
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.088
|
Human |
|
|
megakaryocyte differentiation
|
GO:0030219 |
26 |
0.087
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.087
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.087
|
Human |
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.086
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.086
|
|
|
|
cell chemotaxis
|
GO:0060326 |
81 |
0.085
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.085
|
|
|
|
actin filament bundle assembly
|
GO:0051017 |
40 |
0.085
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.084
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
85 |
0.083
|
Human |
|
|
organelle localization
|
GO:0051640 |
179 |
0.083
|
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.083
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.081
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.079
|
Human |
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.078
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.076
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.075
|
|
|
|
activation of rac gtpase activity
|
GO:0032863 |
2 |
0.074
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.074
|
|
|
|
actin filament polymerization
|
GO:0030041 |
44 |
0.074
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.073
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.072
|
|
|
|
negative regulation of map kinase activity
|
GO:0043407 |
34 |
0.071
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.070
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.070
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.070
|
|
|
|
regulation of phospholipase c activity
|
GO:1900274 |
3 |
0.068
|
|
|
|
homotypic cell cell adhesion
|
GO:0034109 |
28 |
0.068
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.068
|
Human |
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.067
|
Human |
|
|
regulation of natural killer cell activation
|
GO:0032814 |
22 |
0.065
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.064
|
|
|
|
syncytium formation
|
GO:0006949 |
43 |
0.064
|
|
|
|
activation of phospholipase c activity
|
GO:0007202 |
2 |
0.064
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.063
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.063
|
Human |
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.062
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.061
|
|
|
|
regulation of calcium ion transport
|
GO:0051924 |
69 |
0.060
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.059
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.059
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.059
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.058
|
|
|
|
t cell selection
|
GO:0045058 |
34 |
0.058
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.058
|
|
|
|
calcium mediated signaling
|
GO:0019722 |
46 |
0.057
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.057
|
Human |
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.057
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.057
|
|
|
|
dendritic spine maintenance
|
GO:0097062 |
4 |
0.057
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.057
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.056
|
|
|
|
cell adhesion mediated by integrin
|
GO:0033627 |
18 |
0.055
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.055
|
Human |
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.055
|
Human |
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.054
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.054
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.054
|
|
|
|
protein polymerization
|
GO:0051258 |
57 |
0.053
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.053
|
|
|
|
neuron projection extension
|
GO:1990138 |
64 |
0.053
|
|
|
|
regulation of actin polymerization or depolymerization
|
GO:0008064 |
45 |
0.052
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.052
|
Human |
|
|
maternal determination of anterior posterior axis embryo
|
GO:0008358 |
2 |
0.052
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.052
|
Human |
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.052
|
Human |
|
|
antigen receptor mediated signaling pathway
|
GO:0050851 |
64 |
0.051
|
|
|
|
regulation of cell shape
|
GO:0008360 |
39 |
0.051
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.051
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.051
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.050
|
Human |
|
|
syncytium formation by plasma membrane fusion
|
GO:0000768 |
42 |
0.050
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.050
|
Human |
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.048
|
Human |
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.048
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.048
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.048
|
Human |
|
|
digestive system development
|
GO:0055123 |
200 |
0.048
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.048
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.047
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.047
|
|
|
|
dephosphorylation
|
GO:0016311 |
129 |
0.047
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.047
|
|
|
|
lamellipodium organization
|
GO:0097581 |
29 |
0.047
|
|
|
|
neutrophil chemotaxis
|
GO:0030593 |
36 |
0.046
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.046
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.045
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.045
|
Human |
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.045
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.045
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.044
|
|
|
|
myeloid leukocyte activation
|
GO:0002274 |
83 |
0.043
|
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
79 |
0.043
|
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
125 |
0.043
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.043
|
|
|
|
membrane tubulation
|
GO:0097320 |
4 |
0.043
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.043
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.043
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.042
|
|
|
|
positive regulation of calcium mediated signaling
|
GO:0050850 |
15 |
0.042
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.042
|
|
|
|
positive regulation of phospholipase c activity
|
GO:0010863 |
2 |
0.042
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
88 |
0.041
|
Human |
|
|
cell maturation
|
GO:0048469 |
127 |
0.041
|
|
|
|
vesicle organization
|
GO:0016050 |
60 |
0.041
|
|
|
|
substrate dependent cell migration
|
GO:0006929 |
18 |
0.041
|
|
|
|
cell cell junction organization
|
GO:0045216 |
72 |
0.041
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.041
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.040
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.040
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.040
|
Human |
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
70 |
0.039
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.039
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.039
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.039
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.039
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.039
|
|
|
|
positive regulation of tor signaling
|
GO:0032008 |
3 |
0.039
|
|
|
|
immune response regulating cell surface receptor signaling pathway involved in phagocytosis
|
GO:0002433 |
1 |
0.039
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.039
|
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.038
|
|
|
|
establishment of organelle localization
|
GO:0051656 |
122 |
0.038
|
|
|
|
regulation of homotypic cell cell adhesion
|
GO:0034110 |
13 |
0.037
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.037
|
|
|
|
integrin mediated signaling pathway
|
GO:0007229 |
27 |
0.037
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.037
|
Human |
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.037
|
|
|
|
negative regulation of myeloid dendritic cell activation
|
GO:0030886 |
3 |
0.037
|
|
|
|
erbb signaling pathway
|
GO:0038127 |
32 |
0.037
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.037
|
|
|
|
positive regulation of phospholipase activity
|
GO:0010518 |
3 |
0.036
|
|
|
|
t cell receptor signaling pathway
|
GO:0050852 |
46 |
0.036
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.036
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.036
|
Human |
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.036
|
|
|
|
positive regulation of t cell activation
|
GO:0050870 |
101 |
0.035
|
|
|
|
adherens junction maintenance
|
GO:0034334 |
1 |
0.035
|
|
|
|
myosin filament organization
|
GO:0031033 |
3 |
0.035
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.035
|
Human |
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.035
|
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.035
|
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.035
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.034
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.034
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.034
|
|
|
|
establishment or maintenance of cytoskeleton polarity
|
GO:0030952 |
2 |
0.034
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.033
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.033
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.033
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.033
|
|
|
|
regulation of calcium ion transport into cytosol
|
GO:0010522 |
31 |
0.033
|
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.033
|
|
|
|
calcium ion transport into cytosol
|
GO:0060402 |
48 |
0.033
|
|
|
|
positive regulation of actin nucleation
|
GO:0051127 |
3 |
0.032
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.032
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.032
|
|
|
|
negative regulation of ras protein signal transduction
|
GO:0046580 |
18 |
0.032
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.032
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.031
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.031
|
|
|
|
myeloid cell activation involved in immune response
|
GO:0002275 |
34 |
0.031
|
|
|
|
arp2 3 complex mediated actin nucleation
|
GO:0034314 |
3 |
0.031
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.031
|
|
|
|
interleukin 4 production
|
GO:0032633 |
24 |
0.031
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.031
|
|
|
|
positive regulation of actin filament polymerization
|
GO:0030838 |
26 |
0.031
|
|
|
|
protein autophosphorylation
|
GO:0046777 |
61 |
0.031
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.031
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.031
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.031
|
|
|
|
regulation of erythrocyte differentiation
|
GO:0045646 |
23 |
0.031
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.030
|
|
|
|
phagocytosis
|
GO:0006909 |
66 |
0.030
|
|
|
|
positive regulation of myeloid cell differentiation
|
GO:0045639 |
43 |
0.030
|
|
|
|
cytosolic calcium ion transport
|
GO:0060401 |
48 |
0.030
|
|
|
|
leukocyte aggregation
|
GO:0070486 |
1 |
0.030
|
|
|
|
gamma delta t cell activation
|
GO:0046629 |
13 |
0.030
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.030
|
|
|
|
mitochondrion distribution
|
GO:0048311 |
4 |
0.030
|
|
|
|
t cell differentiation in thymus
|
GO:0033077 |
77 |
0.030
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.030
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.030
|
|
|
|
platelet aggregation
|
GO:0070527 |
20 |
0.030
|
|
|
|
establishment or maintenance of microtubule cytoskeleton polarity
|
GO:0030951 |
1 |
0.030
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.029
|
Human |
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.029
|
Human |
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.029
|
|
|
|
cell junction maintenance
|
GO:0034331 |
4 |
0.029
|
|
|
|
substrate dependent cell migration cell extension
|
GO:0006930 |
4 |
0.029
|
|
|
|
regulation of bone resorption
|
GO:0045124 |
24 |
0.029
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.029
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.028
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.028
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.028
|
|
|
|
granulocyte migration
|
GO:0097530 |
43 |
0.028
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
88 |
0.028
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.028
|
Human |
|
|
positive regulation of rho gtpase activity
|
GO:0032321 |
41 |
0.028
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.028
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.028
|
Human |
|
|
striated muscle myosin thick filament assembly
|
GO:0071688 |
1 |
0.028
|
|
|
|
actin filament based movement
|
GO:0030048 |
23 |
0.027
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.027
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.027
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.027
|
Human |
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.027
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.027
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.027
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.026
|
|
|
|
intracellular mrna localization
|
GO:0008298 |
4 |
0.026
|
|
|
|
membrane invagination
|
GO:0010324 |
17 |
0.026
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.026
|
|
|
|
regulation of protein binding
|
GO:0043393 |
60 |
0.026
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.026
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.026
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.026
|
Human |
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.026
|
|
|
|
positive t cell selection
|
GO:0043368 |
23 |
0.026
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.026
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.026
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.026
|
|
|
|
platelet activation
|
GO:0030168 |
40 |
0.025
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.025
|
Human |
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.025
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.025
|
|
|
|
regulation of nuclear division
|
GO:0051783 |
56 |
0.025
|
|
|
|
positive regulation of b cell receptor signaling pathway
|
GO:0050861 |
4 |
0.025
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.025
|
Human |
|
|
body morphogenesis
|
GO:0010171 |
45 |
0.025
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.025
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in smooth muscle cell differentiation
|
GO:2000721 |
2 |
0.025
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.024
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.024
|
Human |
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.024
|
Human |
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.024
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.024
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.024
|
|
|
|
peptidyl serine phosphorylation
|
GO:0018105 |
74 |
0.024
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
83 |
0.024
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.024
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.024
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.024
|
|
|
|
activation of mapk activity
|
GO:0000187 |
59 |
0.024
|
|
|
|
detection of stimulus
|
GO:0051606 |
84 |
0.024
|
|
|
|
negative regulation of protein serine threonine kinase activity
|
GO:0071901 |
49 |
0.023
|
|
|
|
osteoclast differentiation
|
GO:0030316 |
62 |
0.023
|
|
|
|
positive regulation of rac gtpase activity
|
GO:0032855 |
14 |
0.023
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.023
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.023
|
|
|
|
tolerance induction to self antigen
|
GO:0002513 |
4 |
0.023
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.023
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.023
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.023
|
|
|
|
sensory perception of mechanical stimulus
|
GO:0050954 |
107 |
0.023
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.023
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.023
|
|
|
|
leukocyte tethering or rolling
|
GO:0050901 |
3 |
0.022
|
|
|
|
b cell receptor signaling pathway
|
GO:0050853 |
20 |
0.022
|
|
|
|
regulation of cell adhesion mediated by integrin
|
GO:0033628 |
13 |
0.022
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.022
|
|
|
|
nucleus localization
|
GO:0051647 |
20 |
0.022
|
|
|
|
myosin filament assembly
|
GO:0031034 |
2 |
0.022
|
|
|
|
oocyte development
|
GO:0048599 |
33 |
0.022
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.022
|
Human |
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.022
|
|
|
|
positive regulation of leukocyte differentiation
|
GO:1902107 |
86 |
0.022
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.022
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.022
|
|
|
|
establishment of vesicle localization
|
GO:0051650 |
81 |
0.022
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.022
|
|
|
|
oocyte anterior posterior axis specification
|
GO:0007314 |
2 |
0.021
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.021
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.021
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.021
|
|
|
|
post embryonic organ development
|
GO:0048569 |
17 |
0.021
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.021
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.021
|
Human |
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.021
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.021
|
|
|
|
lysosome localization
|
GO:0032418 |
20 |
0.021
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.021
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
81 |
0.021
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.021
|
|
|
|
cytokine biosynthetic process
|
GO:0042089 |
68 |
0.021
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.021
|
Human |
|
|
cell junction assembly
|
GO:0034329 |
52 |
0.020
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.020
|
|
|
|
defense response to virus
|
GO:0051607 |
68 |
0.020
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.020
|
|
|
|
fucose metabolic process
|
GO:0006004 |
1 |
0.020
|
|
|
|
nk t cell differentiation
|
GO:0001865 |
8 |
0.020
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.020
|
|
|
|
regulation of podosome assembly
|
GO:0071801 |
3 |
0.020
|
|
|
|
bone remodeling
|
GO:0046849 |
53 |
0.020
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.020
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.020
|
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.020
|
|
|
|
microglia development
|
GO:0014005 |
2 |
0.020
|
|
|
|
apical constriction
|
GO:0003383 |
4 |
0.020
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.020
|
Human |
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.019
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.019
|
|
|
|
vesicle localization
|
GO:0051648 |
86 |
0.019
|
|
|
|
positive regulation of cytoskeleton organization
|
GO:0051495 |
49 |
0.019
|
|
|
|
membrane fusion
|
GO:0061025 |
38 |
0.019
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
91 |
0.019
|
|
|
|
formation of radial glial scaffolds
|
GO:0021943 |
4 |
0.019
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.019
|
|
|
|
rac protein signal transduction
|
GO:0016601 |
13 |
0.019
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.019
|
|
|
|
ectodermal digestive tract development
|
GO:0007439 |
1 |
0.019
|
|
|
|
regulation of erk1 and erk2 cascade
|
GO:0070372 |
71 |
0.018
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.018
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.018
|
|
|
|
sensory perception of touch
|
GO:0050975 |
2 |
0.018
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.018
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.018
|
|
|
|
negative regulation of mast cell activation
|
GO:0033004 |
6 |
0.018
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.018
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.018
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.018
|
|
|
|
synapse assembly
|
GO:0007416 |
56 |
0.018
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.018
|
|
|
|
negative regulation of immune effector process
|
GO:0002698 |
55 |
0.018
|
|
|
|
vesicle fusion
|
GO:0006906 |
16 |
0.018
|
|
|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.018
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.018
|
Human |
|
|
spermatid development
|
GO:0007286 |
108 |
0.018
|
|
|
|
superoxide metabolic process
|
GO:0006801 |
27 |
0.018
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.018
|
|
|
|
regulation of cell division
|
GO:0051302 |
76 |
0.017
|
|
|
|
face development
|
GO:0060324 |
38 |
0.017
|
|
|
|
pole plasm assembly
|
GO:0007315 |
2 |
0.017
|
|
|
|
membrane lipid metabolic process
|
GO:0006643 |
53 |
0.017
|
|
|
|
segmentation
|
GO:0035282 |
93 |
0.017
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.017
|
Human |
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.017
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.017
|
|
|
|
phagolysosome assembly
|
GO:0001845 |
3 |
0.017
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.017
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.017
|
|
|
|
oogenesis
|
GO:0048477 |
56 |
0.017
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.017
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.017
|
|
|
|
positive regulation of myeloid leukocyte differentiation
|
GO:0002763 |
26 |
0.016
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.016
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.016
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.016
|
|
|
|
adherens junction organization
|
GO:0034332 |
28 |
0.016
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.016
|
|
|
|
positive regulation of t cell proliferation
|
GO:0042102 |
52 |
0.016
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.016
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.016
|
Human |
|
|
thymic t cell selection
|
GO:0045061 |
22 |
0.016
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.016
|
Human |
|
|
sensory system development
|
GO:0048880 |
3 |
0.016
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.016
|
|
|
|
regulation of t cell proliferation
|
GO:0042129 |
92 |
0.016
|
|
|
|
regulation of toll like receptor 2 signaling pathway
|
GO:0034135 |
3 |
0.016
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.016
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.015
|
|
|
|
mast cell activation involved in immune response
|
GO:0002279 |
20 |
0.015
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.015
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.015
|
|
|
|
fc receptor mediated inhibitory signaling pathway
|
GO:0002774 |
1 |
0.015
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.015
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.015
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.015
|
|
|
|
actin mediated cell contraction
|
GO:0070252 |
15 |
0.015
|
|
|
|
sphingosine 1 phosphate signaling pathway
|
GO:0003376 |
3 |
0.015
|
|
|
|
neutrophil migration
|
GO:1990266 |
37 |
0.015
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.015
|
|
|
|
positive regulation of t cell extravasation
|
GO:2000409 |
2 |
0.015
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.015
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.015
|
|
|
|
positive regulation of podosome assembly
|
GO:0071803 |
3 |
0.015
|
|
|
|
regulation of synapse assembly
|
GO:0051963 |
29 |
0.015
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.015
|
Human |
|
|
erk1 and erk2 cascade
|
GO:0070371 |
77 |
0.015
|
|
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.015
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.015
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.015
|
|
|
|
epithelium migration
|
GO:0090132 |
63 |
0.015
|
|
|
|
regulation of lymphocyte apoptotic process
|
GO:0070228 |
41 |
0.015
|
|
|
|
regulation of osteoblast proliferation
|
GO:0033688 |
15 |
0.015
|
|
|
|
regulation of peptide hormone secretion
|
GO:0090276 |
75 |
0.015
|
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.014
|
|
|
|
mast cell activation
|
GO:0045576 |
27 |
0.014
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.014
|
|
|
|
platelet derived growth factor receptor signaling pathway
|
GO:0048008 |
32 |
0.014
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.014
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.014
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.014
|
|
|
|
regulation of retina development in camera type eye
|
GO:1902866 |
3 |
0.014
|
|
|
|
ceramide metabolic process
|
GO:0006672 |
31 |
0.014
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.014
|
|
|
|
epidermal growth factor receptor signaling pathway
|
GO:0007173 |
28 |
0.014
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.014
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.014
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.014
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.014
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.014
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.014
|
Human |
|
|
positive regulation of lipid metabolic process
|
GO:0045834 |
40 |
0.013
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.013
|
|
|
|
regulation of lipase activity
|
GO:0060191 |
15 |
0.013
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.013
|
|
|
|
positive regulation of cytosolic calcium ion concentration
|
GO:0007204 |
65 |
0.013
|
|
|
|
positive regulation of gamma delta t cell differentiation
|
GO:0045588 |
6 |
0.013
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.013
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.013
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.013
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.013
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.013
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.013
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.013
|
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.013
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.013
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.013
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.013
|
|
|
|
insulin secretion
|
GO:0030073 |
89 |
0.013
|
|
|
|
negative regulation of mapk cascade
|
GO:0043409 |
65 |
0.013
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.013
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.013
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.013
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.013
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.013
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.013
|
|
|
|
regulation of bone remodeling
|
GO:0046850 |
28 |
0.013
|
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.013
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.013
|
|
|
|
microglia differentiation
|
GO:0014004 |
2 |
0.013
|
|
